21.06.2017

MagForce AG hosts live demonstration of NanoTherm® Therapy at Long Night of the Sciences 2017 in Berlin on June 24, 2017

Berlin, Germany, and Nevada, USA, June 21, 2017 - MagForce AG (Frankfurt, Scale, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, is pleased to be part of this year’s Long Night of the Sciences (“Lange Nacht der Wissenschaften”) on ...

 

08.06.2017

MagForce AG Co-Sponsors Brain Cancer Patient Event of University Hospital Münster held on occasion of the 2017 World Brain Tumor Day

Berlin, Germany and Nevada, USA, June 08, 2017 - MagForce AG (Frankfurt, Scale, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, is delighted to announce that the Company is again co-sponsoring an event for brain cancer patients and ...

 

10.05.2017

MagForce AG reports highlights of Symposium for Focal Therapy in Glioblastoma at WFNOS 2017 Meeting

Berlin, Germany, and Nevada, USA, May 10, 2017 - MagForce AG (Frankfurt, Scale, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, is pleased to announce that the Company was the host of the very successful Scientific Symposium titled ...

 

09.05.2017

MagForce AG publishes Directors' Dealings

download PDF

 

05.05.2017

MagForce AG publishes Directors' Dealings

download PDF